Alcon to Sell BlephEx Eyelid Cleaning Device and LashCam iR WIFI Camera in the U.S.

Alcon has announced an agreement that grants exclusive rights to sell the BlephEx^® technology and accompanying products in the U.S. effective May 1, 2021. The partnership with BlephEx, LLC, the pioneer in bacterial biofilm theory, demonstrates Alcon’s ongoing commitment to bringing forth transformative innovations for eye care practices. The BlephEx eyelid cleaning device and LashCam™ iR WIFI camera will join Alcon’s innovative Systane^® iLux^® technology in meeting the in-office, ocular surface health needs of patients.

”Since launch, Systane iLux and the wrap-around support programs have provided practice and patient benefits around the country,” said Fred Ellis, Head of Dry Eye Devices at Alcon. “While this has been a great source of pride for Alcon, we want to continue providing solutions that help Eye Care Professionals address a range of ocular surface issues. Our partnership with BlephEx will increase in-office options during a time when we are seeing more ocular surface issues, and put another tool in the arsenal to address unmet patient needs.”

The BlephEx handpiece is a micro-blepharoexfoliation device that spins a soft medical grade micro-sponge along the edge of the eyelids and lashes, removing scurf and debris. This in-office procedure lasts 6 to 8 minutes and has been shown to effectively remove accumulated debris and bacterial biofilm from the eyelid surface.¹ The LashCam iR, a WIFI camera with infrared light that instantly transmits hi-res 80X magnification images of eyelid margins, will complement both the BlephEx and Systane iLux procedures by allowing doctors to show patients their meibomian gland structure to aid with patient education.

“Addressing Meibomian Gland Dysfunction (MGD) is a significant unmet need for the anterior segment Eye Care Professional,” said Dr. Eric Donnenfeld,* ophthalmologist, Ophthalmic Consultants of Connecticut. “Systane iLux and BlephEx are perfect partners because removing debris and bacterial biofilm on the eyelid margin and unclogging meibomian glands through thermal pulsation are effective for supporting ocular health and treating MGD, respectively.”  

The BlephEx and LashCam iR devices can be purchased alongside the Systane iLux MGD Treatment System, which includes:

• Systane iLux device
• Dry Eye Excellence Program (DEEP™) for practice support
• SystaneMyEyes^® patient retention program, including an iLux patient care kit
• Patient education information at GetToRootCause.com
• Professional product information at SystaneiLux.com

“The incidence of ocular surface health issues in the U.S. is significant and can impact almost every area of my practice,” said Dr. Paul Karpecki,* optometrist, Keplr Vision. “Supporting the ocular surface has immeasurable benefits for patient clinical outcomes, and Systane iLux and BlephEx will be beneficial for patients managing ocular surface health.”